M. El-gohary et al., Deltamethrin-induced testicular apoptosis in rats: the protective effect of nitric oxide synthase inhibitor, TOXICOLOGY, 132(1), 1999, pp. 1-8
This study is the first to examine and characterize the testicular apoptosi
s which might be induced due to exposure of male rats to deltamethrin. Furt
hermore, the role which might be played by nitric oxide (NO), as well as th
e other reactive oxygen species (ROS) in controlling this testicular apopto
sis was assessed. Apoptosis was evaluated by DNA fragmentation detected by
agarose gel electrophoresis and cellular morphology on testicular tissue se
ctions. It was found that administration of deltamethrin (1 mg/kg daily for
21 days) to animals resulted in characteristic DNA migration patterns (lad
dering), thereby providing evidence that apoptosis is the major mechanism o
f cell death in the testicular tissues. In addition, histopathological exam
ination of testicular tissue sections showed that apoptosis was confined to
the basal germ cells, primary and secondary spermatocytes. These changes,
in addition to the appearance of Sertoli cell vacuoles in deltamethrin-into
xicated animals, indicates the suppression of spermatogenesis. At the same
time, the plasma levels of both NO and lipid peroxides measured as malondia
ldehyde (MDA) were found to be significantly increased in deltamethrin-trea
ted animals. Administration of NO synthase (NOS) inhibitors such as NG-nitr
o monomethyl L-arginine hydrochloride (L-NMMA, 1 mg/kg) to rats 2 h before
exposure to deltamethrin was effective in the reduction of the typically te
sticular apoptotic DNA fragmentation pattern and the associated histopathol
ogical changes. These findings may suggest that deltamethrin-induced testic
ular apoptosis is mediated by NO. Therefore, the pharmacological manipulati
on of apoptosis by selective NOS inhibitors such as L-NMMA may offer new po
ssibilities for the control of deltamethrin-induced testicular dysfunction
and infertility in the future. (C) 1999 Elsevier Science Ireland Ltd. All r
ights reserved.